PUXANO at BioJapan and TechBIZKON: Connecting with Japan's Biotech Community

7 October 2026

PUXANO recently travelled to Japan, where CEO Wouter Van Putte took part in BioJapan and pitched at TechBIZKON.
During the trip, Wouter had the opportunity to meet fellow Flemish companies, Japanese partners and potential customers, while introducing PUXANO’s work in structural biology and protein research.
A key highlight was the first presentation of PUXANO’s patient-specific structure-based drug design (SBDD) platform, showcasing our approach to combining computational protein design with experimental structural biology.
The visit was a great opportunity to explore new collaborations, exchange ideas and strengthen PUXANO’s connections within Japan’s growing biotech ecosystem.
A big thank you to Flanders Investment & Trade (FIT) and everyone who helped make this trip a success!

Read also

Sign Up for Our Newsletter

Stay updated on the latest in protein design, AI-driven engineering, and groundbreaking research. Subscribe now to get exclusive insights and updates.